Outsourcing Pharma
AUGUST 17, 2023
BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.
STAT
AUGUST 18, 2023
It was Thanksgiving 2021, and Michael Young was at Target buying a turkey baster. “I’m in the parking lot, and my chest starts to feel like somebody’s sitting on me,” Young recounted. But he didn’t think too much of it and waited until February to tell the doctor about these on-and-off chest pains. “8:30 a.m.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
AUGUST 17, 2023
The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.
ALiEM - Pharm Pearls
AUGUST 18, 2023
A middle-aged man with a past medical history of hypertension and tobacco use disorder presented to the Emergency Department after evaluation by an ophthalmologist. He complained of ten days of a right-sided headache and three days of diplopia. He denied eye pain, pain with eye movements, photophobia, and vision loss. Physical Exam Vitals : Temp 98.4 °F (36.9 °C); BP 122/72; Pulse 90; Resp 16; SpO2 100% Neuro : Ptosis, “down and out” deviation and pupil dilation of the right eye were noted.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharma Dive
AUGUST 18, 2023
BSCA has kicked CVS Caremark, the largest pharmacy benefit manager in the country, to the curb and is electing to carve out various pharmacy functions with companies like Amazon instead.
STAT
AUGUST 17, 2023
The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates. It also provided a stable stream of wealth for top executives, who collectively pocketed billions of dollars in what was otherwise a rough patch for the economy. By almost every measure, 2022 was a bad year for the stock market.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
AUGUST 17, 2023
Annual Drug Patent Expirations for LUMASON Lumason is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Bracco drug LUMASON appeared first on DrugPatentWatch - Make Better Decisions.
BioPharma Dive
AUGUST 15, 2023
More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.
STAT
AUGUST 17, 2023
When someone says the word embryo, what do you think of? Probably that picture you’ve seen a thousand times on a thousand different news articles: a translucent orb swelling with cytoplasm being prodded by a microinjection needle under the light of a microscope. The mainstreaming of IVF, or in vitro fertilization, has familiarized new generations of people with what the earliest stages of human development entails.
PharmaVoice
AUGUST 15, 2023
Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Patent Watch
AUGUST 16, 2023
Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are nine patents… The post New patent for United Therap drug REMODULIN appeared first on DrugPatentWatch - Make Better Decisions.
BioPharma Dive
AUGUST 17, 2023
A combination of Trodelvy and Merck’s Keytruda appears active against lung tumors, but has a high bar to clear and faces competition from AstraZeneca and Daiichi Sankyo.
STAT
AUGUST 17, 2023
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid-19 vaccines, a victory for advocates who alleged that authorities may have overpaid for the shots and that the lack of transparency masked pharmaceutical profits at the public’s expense. At issue are contracts signed by the South African government with several companies — including Johnson & Johnson and Pfizer — that provided millions of Covid-19 vaccines du
PharmaVoice
AUGUST 18, 2023
With Flagship and Pfizer’s newly announced partnership to find the next big blockbuster, we’re examining some of the VC fund’s biggest successes and failures to date.
Pharmacy Joe
AUGUST 16, 2023
In this episode, I’ll discuss the pharmacist’s role in predicting the need for intubation. Episode 844: Why A Pharmacist Should Learn to Predict the Need for Intubation Subscribe on iTunes , Android , or Stitcher Because of how drug delivery systems are set up in most US hospitals with medications stored in automated dispensing cabinets, there can be a considerable delay between the time a physician makes a decision to intubate a patient until the time the team is ready with medications to
PharmaTech
AUGUST 16, 2023
FDA granted accelerated approval to Elrexfio (elranatamab-bcmm) for adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.
STAT
AUGUST 16, 2023
The nation’s health faces a dual threat — one anticipated, the other, self-inflicted. Covid-19 has not gone away; the Centers for Disease Control and Prevention reports that infections are showing signs of a late summer wave. The new strain, EG.5 , spreads easily and is more resistant to neutralizing antibodies but does not, to date, seem to be more virulent.
The Pharmacist
AUGUST 15, 2023
The Chancellor of the Exchequer, Jeremy Hunt, has joined local Surrey residents in protesting the potential closure of a local Boots pharmacy. Mr Hunt, who was the Secretary of State for Health and Social Care between 2012 and 2018, has added his name to two local petitions against the potential closure of a Boots pharmacy […] The post Chancellor and former health secretary protests local pharmacy closure appeared first on The Pharmacist.
BioPharma Dive
AUGUST 14, 2023
Elrexfio is the third bispecific antibody cleared to treat the blood cancer, and will compete with other therapies that target the “BCMA” protein on myeloma cells.
Drug Patent Watch
AUGUST 15, 2023
A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases… The post Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review appeared first on DrugPatentWatch - Make Better Decisions.
STAT
AUGUST 15, 2023
Every year, doctors get better tools to fight cancer. Engineered cancer-killing cells, immunotherapies, targeted drugs, and more are helping clinicians cure more patients. Increasingly, though, oncologists are trying to use less radiation, long one of the main pillars of cancer therapy. In some cases, they are even keeping certain patients with low-risk tumors off radiation entirely.
PharmExec
AUGUST 15, 2023
Bridget Seay of epocrates delves into drug launches in a digital-forward market, exploring how pharmaceutical companies can navigate complex patient journeys, strike a balance between traditional and digital marketing tactics, and ethically engage with healthcare professionals and empowered patients amidst ever-changing regulations.
Express Pharma
AUGUST 13, 2023
Mankind Pharma organised an organ donation drive in collaboration with the National Organ and Tissue Transplant Organisation (NOTTO) and prominent medical experts. The event featured a live panel discussion between Dr Sandeep Guleria, Senior Consultant and Transplant Surgeon at Indraprastha Hospital and Apollo Hospital; Dr Subhash Gupta, Chairman of the Centre for Liver & Biliary Sciences, specialising in Liver Transplant and Biliary Sciences, along with Robotic Surgery at Max Super Special
BioPharma Dive
AUGUST 16, 2023
The decision stands in contrast to the agency’s plans for a would-be rival gene editing treatment from Vertex Pharmaceuticals and CRISPR Therapeutics that is also under a regulatory review.
STAT
AUGUST 15, 2023
As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected. The algorithm, called Viz HCM and developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration.
PharmaState Academy
AUGUST 18, 2023
???????????: To be awarded with 3CPhE (Continuing Pharma Education) points. Registrations Open Limited Seats Interest Form For Next Batch We limit the number of participants in a batch so that high-quality interactive learning can happen. In case you have missed this batch, you can fill out the Interest form for the next batch. We will send you the information, once the registrations open for the next batch.
FDA Law Blog: Biosimilars
AUGUST 16, 2023
By Douglas B. Farquhar — Francis Godwin, Director of the Office of Manufacturing Quality of the Office of Compliance at FDA’s Center for Drug Evaluation and Research provided useful information (presentation attached here ) Tuesday at the GMP by the Sea Conference. He talked about regulatory discretion being exercised for drug manufacturing facilities with serious compliance problems, about how firms should respond to FDA inspectional observations, and about an upcoming guidance that will be of
BioPharma Dive
AUGUST 14, 2023
Stephen Apps discusses how technology can help improve the speed and quality of clinical research and why a dedicated, cross-functional approach is needed to maximize its value for smaller biotechs.
STAT
AUGUST 14, 2023
Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding. Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.
FADIC
AUGUST 12, 2023
6 Tips to beat the afternoon slump Follow Japan’s 80% Rule: Most people lose 2-3 hours daily to the afternoon slump. But it doesn’t have to be that way. Imagine you reclaiming 14+ hours weekly of high energy. You could: • Boost productivity • Deepen relationships • Get in the best shape of your life 6 tips to beat the afternoon slump: 1) Follow Japan’s 80% Rule “Eat until you’re only 80% full.” Overeating makes the body divert blood &
The Pharmacist
AUGUST 16, 2023
Places are available for up to 840 pharmacy technicians to apply for new fully funded training launching in September. The training aims to enable community pharmacy technicians to take on responsibility while more pharmacists train as independent prescribers. Pharmacy technicians will be trained in consultation skills, therapeutics, clinical decision making and assessment skills as well […] The post New training for pharmacy technicians to launch in September appeared first on The Pharmac
Express Pharma
AUGUST 14, 2023
Lupin has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Doxycycline Hyclate Delayed-Release Tablets USP, 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 120 mg, 150 mg, and 200 mg, to market a generic equivalent of Doryx Delayed-Release Tablets, 50 mg, 75 mg, 80 mg, 100 mg, 150 mg, and 200 mg and Doryx MPC Delayed Release Tablets, 60 mg and 120 mg, of Mayne Pharma International.
STAT
AUGUST 15, 2023
WASHINGTON — Patient advocates are warning that a recent proposal from the Food and Drug Administration meant to reduce consumers’ salt intake could inadvertently kill those with kidney disease, particularly Black Americans. The proposal at issue, which is still in draft form , was unveiled by the FDA in April. It would allow the use of salt substitutes in foods that have so-called standards of identity, regulations governing what ingredients must go in popular foods, like ketchup,
European Pharmaceutical Review
AUGUST 16, 2023
Sandoz has announced positive results from the MYLIGHT Phase III study for its biosimilar aflibercept, for patients living with wet macular degeneration. The confirmatory efficacy and safety study ( NCT04864834 ) demonstrated therapeutic equivalence between the biosimilar aflibercept and the reference biologic, Eylea®. The study met its primary efficacy endpoint, showing therapeutic equivalence in mean change of best corrected visual acuity (BCVA) from baseline to week 8 between the biosimilar a
The Pharmacist
AUGUST 17, 2023
NICE has recommended four digital platforms to be used by NHS weight management services to help assess patients and prescribe weight-loss medication for obesity. Draft guidance has proposed the use of platforms that can help clinicians support patients psychologically, provide monitoring, and even allow prescription. The platforms put forward – Liva, Oviva, Roczen, and Second Nature […] The post NICE gives go ahead to digital platforms for weight loss services appeared first on The Pharma
Expert insights. Personalized for you.
98 
Let's personalize your content